Test Code 1DIS Human Leukocyte Antigens (HLA) A-B-C Disease Association Typing Low Resolution, Blood
Specimen Required
Container/Tube: Yellow top (ACD solution A or B)
Specimen Volume: 6 mL
Collection Instructions: Send whole blood in original tube. Do not aliquot.
Additional Information: Specimen acceptability is based on extracted DNA concentration and not sample age.
Forms
If not ordering electronically, complete, print, and send a Hematopathology/Cytogenetics Test Request (T726) with the specimen.
Secondary ID
609354Useful For
Determining class I human leukocyte antigens (HLA) on specimens for those patients who have become refractory to platelet transfusions and identify potential disease associations or markers for drug hypersensitivity
Method Name
Polymerase Chain Reaction (PCR)/Next-Generation Sequencing (NGS)
Reporting Name
HLA-A-B-C DisAssoc Typing LowRes,BSpecimen Type
Whole Blood ACDSpecimen Minimum Volume
3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole Blood ACD | Ambient (preferred) | ||
Refrigerated |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Clinical Information
Human leukocyte antigens (HLA) are regulators of the immune response. HLA class I typing is used to identify HLA-matched platelets for alloimmunized refractory patients and identify presence of HLA antigens associated with a number of diseases or as drug hypersensitivity markers Class I HLA antigens include A, B, and C loci. This assay is designed to provide low-to-medium resolution for HLA class I typing (A, B, C). Low-to-medium resolution defines the typing at the antigen level (first field). This contrasts with high-resolution typing, which defines typing at the allele (molecular) level (second field or higher).
Reference Values
Not applicable
Interpretation
Interpretation depends on the rationale for ordering the test.
Day(s) Performed
Monday, Thursday
Report Available
7 to 17 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81372
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
1DIS | HLA-A-B-C DisAssoc Typing LowRes,B | 96629-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
1DA02 | ABC DisAssoc Comment | 96625-9 |
1DA03 | A - 1 Equivalent | 13298-5 |
1DA04 | A - 2 Equivalent | 13298-5 |
1DA05 | A - 1 Molecular | 78014-8 |
1DA06 | A - 2 Molecular | 78014-8 |
1DA07 | B - 1 Equivalent | 13299-3 |
1DA08 | B - 2 Equivalent | 13299-3 |
1DA09 | B - 1 Molecular | 78015-5 |
1DA10 | B - 2 Molecular | 78015-5 |
1DA11 | Bw - 1 Equivalent | 96633-3 |
1DA12 | Bw - 2 Equivalent | 96633-3 |
1DA13 | C - 1 Equivalent | 13302-5 |
1DA14 | C - 2 Equivalent | 13302-5 |
1DA15 | C - 1 Molecular | 96636-6 |
1DA16 | C - 2 Molecular | 96636-6 |
LRTM1 | Test Method | 85069-3 |